Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 164 Breast Neoplasms 111 Colorectal Neoplasms 77 Neoplasms 65 Lung Neoplasms 61 Pancreatic Neoplasms 56 Stomach Neoplasms 52 Neoplasm Metastasis 51 Ovarian Neoplasms 45 Rectal Neoplasms 43 Esophageal Squamous Cell Carcinoma 38 Esophageal Neoplasms 38 Head and Neck Neoplasms 34 Squamous Cell Carcinoma of Head and Neck 32 Leukemia, Myeloid, Acute 32 Recurrence 26 Triple Negative Breast Neoplasms 25 Small Cell Lung Carcinoma 24 Precursor Cell Lymphoblastic Leukemia-Lymphoma 24 Glioblastoma 23 Colonic Neoplasms 23 Uterine Cervical Neoplasms 22 Nasopharyngeal Carcinoma 22 Lymphoma 21 Lymphoma, Non-Hodgkin 20 Fallopian Tube Neoplasms 20 Prostatic Neoplasms 17 Melanoma 17 Sarcoma 16 Leukemia 16

Interventions

Propofol 2 Dexmedetomidine 2 serotonin adipinate 1 contrast agent BR1 1 Therapeutics 1 Surgical Procedures, Operative 1 Sevoflurane 1 Serotonin 1 Ropivacaine 1 Paclitaxel 1 Nitrous Oxide 1 Metastasectomy 1 Lidocaine 1 Iohexol 1 Imatinib Mesylate 1 Glycopyrrolate 1 Food, Formulated 1 Fluorouracil 1 FS 069 1 Enoxaparin 1 Embolization, Therapeutic 1 Drug Therapy 1 Doxorubicin 1 Dietary Supplements 1 Cytoreduction Surgical Procedures 1 Continuous Positive Airway Pressure 1 Cisplatin 1 Cell Count 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Abdominal Neoplasms × Drug Therapy × Clear all

NCT03966456 2019-05-29

Real World Study of Four PD-1 Agents in China

The Affiliated Hospital of Qingdao University

Abdominal Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡